Lung cancer is one of the common malignant tumors that threaten human life with serious
incidence and high mortality. According to the histopathological characteristics, lung cancer …

Non-small cell lung cancer (NSCLC) remains by far the single most common malignancy of
lung cancer which causes more and more mortality in recent years. NSCLC accounts for …

Objective To compare the efficacy and safety of first line treatments for patients with
advanced epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer …

Background Lung cancer is the leading cause of cancer-related death worldwide, with non-
small cell lung cancer (NSCLC) accounting for most cases. While radiotherapy has …

Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in
primary and metastatic lung adenocarcinoma - PMC Back to Top Skip to main content NIH …

Background EGFR-mutant non-small cell lung cancer (NSCLC) is prone to leptomeningeal
metastasis (LM) after Tyrosine kinase inhibitors (TKIs) treatment. Our previous study …

Simple Summary Targeted therapies have emerged as newer systemic options for certain
cancers. EGFR-directed Tyrosine Kinase Inhibitors (EGFR-TKIs), which have several …

Radiotherapy, along with other loco-regional interventions, is conventionally utilized as a
palliative approach to alleviate symptoms and mitigate oncological emergencies in …

Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer and a leading
cause of cancer-related deaths worldwide. Using an integrative approach, we analyzed a …

Background The efficacy and safety of osimertinib combined with bevacizumab in non‐small
cell lung cancer (NSCLC) patients with brain metastasis harboring epidermal growth factor …